Chordia Therapeutics (TSE:190A) Days Payable: 0.00 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:190A Chordia Therapeutics Inc TSE:190A
11 GF Score
Price 円77.00
! 1 Warning Sign
View Full Analysis

What is Chordia Therapeutics Days Payable?

Chordia Therapeutics TSE:190A -2.53% 11 Days Payable is 0.00 as of Feb. 2026. GuruFocus rates TSE:190A with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 702 Biotechnology companies, Chordia Therapeutics ranks worse than 142450% on this metric.

Chordia Therapeutics's average Accounts Payable for the six months ended in Feb. 2026 was 円0.00 Mil. Chordia Therapeutics's Cost of Goods Sold for the six months ended in Feb. 2026 was 円510.33 Mil. Hence, Chordia Therapeutics's Days Payable for the six months ended in Feb. 2026 was 0.00.

The historical rank and industry rank for Chordia Therapeutics's Days Payable or its related term are showing as below:

During the past 5 years, Chordia Therapeutics's highest Days Payable was 25.60. The lowest was 25.60. And the median was 25.60.

TSE:190A's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 113.1
* Ranked among companies with meaningful Days Payable only.

Chordia Therapeutics's Days Payable stayed the same from Feb. 2025 (0.00) to Feb. 2026 (0.00).

Chordia Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Chordia Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics Days Payable Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24 Aug25
Days Payable
0.00 0.00 25.60 0.00 0.00

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Days Payable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TSE:190A vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Chordia Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordia Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's Days Payable falls into.


TSE:190A
11GF Score
Chordia Therapeutics Inc TSE:190A
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chordia Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Chordia Therapeutics's Days Payable for the fiscal year that ended in Aug. 2025 is calculated as

Days Payable (A: Aug. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Aug. 2024 ) + Accounts Payable (A: Aug. 2025 )) / count ) / Cost of Goods Sold (A: Aug. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 1425.309*365
=0 / 1425.309*365
=0.00

Chordia Therapeutics's Days Payable for the quarter that ended in Feb. 2026 is calculated as:

Days Payable (Q: Feb. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Aug. 2025 ) + Accounts Payable (Q: Feb. 2026 )) / count ) / Cost of Goods Sold (Q: Feb. 2026 )*Days in Period
=( (0 + 0) / 1 ) / 510.333*365 / 2
=0 / 510.333*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Chordia Therapeutics (TSE:190A) has a Days Payable of 0.00 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chordia Therapeutics and its competitors. Over the past decade, Chordia Therapeutics' Days Payable has ranged from 25.60 to 25.60. According to the industry distribution chart, Chordia Therapeutics ranks #999999 out of 702 companies in the Biotechnology industry.
Is Chordia Therapeutics' Days Payable too high?
Chordia Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 25.60 to a high of 25.60. Based on the distribution chart, Chordia Therapeutics ranks #999999 out of 702 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Chordia Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Chordia Therapeutics' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chordia Therapeutics ranks #999999 out of 702 companies for Days Payable. This places Chordia Therapeutics in the lower half of its industry. The industry median Days Payable is 113.10. Historically, Chordia Therapeutics' own Days Payable has ranged from 25.60 to 25.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chordia Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chordia Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chordia Therapeutics stock overvalued right now?
Chordia Therapeutics (TSE:190A) has a current Days Payable of 0.00. The current Days Payable is 0.00. Chordia Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Chordia Therapeutics (TSE:190A), the current Days Payable is 0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chordia Therapeutics Business Description

Address 2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
11GF Score

Get the complete analysis for TSE:190A

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円77.00
Price